Literature DB >> 3698367

Restoration by recombinant interferon alpha A/D of host defense systems against tumor in immunosuppressed mice.

J Nishimura, K Mitsui, Y Tanaka, R Yamamoto, Y Suhara, H Ishitsuka.   

Abstract

Recombinant human interferon alpha A/D (alpha A/D) restored or augmented host defense systems against tumors in immunosuppressed mice. In normal C57BL/6 mice, inoculation of B16 melanoma F1 cells caused few pulmonary metastasis, whereas in mice pretreated with cyclophosphamide (CY) it caused a high incidence of pulmonary metastasis, leading to earlier death than in the normal mice inoculated with the same dose of the tumor. alpha A/D given after the CY treatment counteracted the deleterious effects of the CY treatment. Since such restorative activity was seen even against the subline of B16 F1 which had been made resistant to its direct antiproliferative effect, alpha A/D seems to exert its effect indirectly through host defense systems. However, this activity of alpha A/D in the mice pretreated with CY was abrogated by inoculation of anti-asialo GM1 serum but not by i-carrageenan. The CY treatment reduced NK activity, while alpha A/D given after the CY treatment restored or augmented the NK cell activity in lung cells and peripheral blood mononuclear cells, but not in spleen cells. These findings suggest that the restoration or augmentation of NK activity in the lung and/or peripheral blood might be the major factor leading to the antimetastatic activity of alpha A/D in the mice treated with CY.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3698367     DOI: 10.1007/bf00053471

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  20 in total

1.  In vitro interactions of purified cloned human interferons on NK cells: enhanced activation.

Authors:  S Targan; N Stebbing
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

2.  Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes.

Authors:  R B Herberman; J R Ortaldo; A Mantovani; D S Hobbs; H F Kung; S Pestka
Journal:  Cell Immunol       Date:  1982-02       Impact factor: 4.868

3.  Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility.

Authors:  O Stutman; C J Paige; E F Figarella
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

4.  Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural killer cell-mediated cytotoxicity.

Authors:  N Hanna
Journal:  Int J Cancer       Date:  1980-11-15       Impact factor: 7.396

5.  Inhibition of experimentally-induced murine metastases by recombinant alpha interferon: correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases.

Authors:  M J Brunda; D Rosenbaum; L Stern
Journal:  Int J Cancer       Date:  1984-09-15       Impact factor: 7.396

6.  Antitumor and antimetastatic activities of human recombinant interferon alpha A/D.

Authors:  J Nishimura; K Mitsui; T Ishikawa; Y Tanaka; R Yamamoto; Y Suhara; H Ishitsuka
Journal:  Clin Exp Metastasis       Date:  1985 Oct-Dec       Impact factor: 5.150

7.  A glycolipid on the surface of mouse natural killer cells.

Authors:  M Kasai; M Iwamori; Y Nagai; K Okumura; T Tada
Journal:  Eur J Immunol       Date:  1980-03       Impact factor: 5.532

8.  Role of natural killer cells in the destruction of circulating tumor emboli.

Authors:  N Hanna; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1980-10       Impact factor: 13.506

9.  Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice.

Authors:  J E Talmadge; K M Meyers; D J Prieur; J R Starkey
Journal:  J Natl Cancer Inst       Date:  1980-11       Impact factor: 13.506

10.  Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

Authors:  S A Rosenberg; J J Mulé; P J Spiess; C M Reichert; S L Schwarz
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  1 in total

1.  Interferon-mediated enhancement of metastasis. Are MHC antigens involved?

Authors:  P L Lollini; C De Giovanni; B Del Re; G Nicoletti; G Prodi; P Nanni
Journal:  Clin Exp Metastasis       Date:  1987 Oct-Dec       Impact factor: 5.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.